You are on page 1of 7

Laser Lipolysis

Paula Amendola Bellotti Schwartz de Azevedo,


Bianca Bretas de Macedo Silva, and Leticia Almeida Silva

Abstract submental area, arms, abdomen, flanks, inner


Studies concerning laser’s direct action on fat surface of thighs, knees, and elbows. Patients
began in 1992. Two years later the first study of with irregularities after previous liposuction or
laser lipolysis was produced. The method was other surgeries are also excellent candidates.
approved by the FDA in October 2006. Laser For areas with more fibrous tissue, such as
lipolysis is a minimally invasive procedure for male breast (gynecomastia), flanks, and back,
the treatment of localized fat, improving the laser lipolysis maybe the only option. Recent
facial and body contour and flaccidity. It con- articles described the use of laser lipolysis for
sists of the application of laser directly on the the treatment of lipoma, as conventional sur-
adipose tissue, based on the principle of selec- gery can result in disfiguring scars when
tive photothermolysis. This method has the treating lesions bigger than 10 cm. Other ques-
advantage to be less traumatic; to cause less tionable indications are axillary hyperhidrosis
bleeding, pain, ecchymosis, and edema; and and cellulite. There are no specific contraindi-
minimizes side effects and complications. The cations. Complications are rare, and when they
postoperative recovery time is reduced when occur they are not specific to the laser.
compared to conventional liposuction. There is
induction of neocollagenesis, which leads to Keywords
cutaneous retraction. Indications include the Laser lipolysis • Fat • Localized fat • Body
contour • Flaccidity • Cutaneous retraction •
Cellulite • Liposuction • Neocollagenesis •
P.A. Bellotti Schwartz de Azevedo (*) Submental • Gynecomastia
Brazilian Society of Dermatology and Brazilian Society of
Dermatology Surgery, Rio de Janeiro, Brazil
e-mail: bellotti.paula@gmail.com;
Contents
draleticiaalmeida@gmail.com; Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 246
laise.almeida@paulabellotti.com.br; Indications and Contraindications . . . . . . . . . . . . . . . . . . . 247
atendimento@paulabellotti.com.br;
rosangela.caetana@paulabellotti.com.br Preoperative Considerations . . . . . . . . . . . . . . . . . . . . . . . 248

B. Bretas de Macedo Silva Technique . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 249


Brazilian Society of Dermatology, Rio de Janeiro, Brazil
e-mail: biancabretas@yahoo.com.br
L. Almeida Silva
Brazilian Society of Laser in Medicine and Surgery, Rio de
Janeiro, RJ, Brazil
e-mail: draleticiaalmeida@gmail.com

# Springer International Publishing AG 2018 245


M.C.A. Issa, B. Tamura (eds.), Lasers, Lights and Other Technologies, Clinical Approaches and Procedures in
Cosmetic Dermatology 3, https://doi.org/10.1007/978-3-319-16799-2_18
246 P.A. Bellotti Schwartz de Azevedo et al.

Postoperative Care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 250 Table 1 Equipment available in the market


Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 250 Wavelength Laser
Commercial name (nm) type
Complications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 250
SmartLipo (Cynosure, 1064/1320 Nd:
Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 250 Westfort, MA) FDA 2006 YAG
ProLipo (Sciton, Palo Alto, 1064/1319 Nd:
Take Home Messages . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 250
CA) YAG
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 250 FDA 2007
CoolLipo (CoolTouch, 1320 Nd:
Roseville, CA) FDA 2008 YAG
LipoLite (Syneron, Yokneam, 1064 Nd:
Introduction Israel) YAG
FDA 2008
In 1992, Apfelberg was the first to describe laser’s SlimLipo (Palomar, 924/975 Diode
direct action on fat. Two years later, he and col- Burlington, MA) FDA 2008
laborators produced the first study of laser lipoly-
sis. However, its benefit was not significantly
demonstrated. This equipment was not approved In 2006, a study by Kim and Geronemus used
by the FDA, and the company Heraeus magnetic resonance to evaluate the volume of fat
Lasersonics abandoned the technology reduction after Laser lipolysis. Seventeen percent
(Apfelberg et al. 1994). of patients achieved a reduction of fat volume
The first study to demonstrate the effect of laser documented by magnetic resonance imaging,
on fat, as well as on the dermis, vessels, and apo- and 37% noticed an improvement in only
crine and eccrine glands, was described between 3 months, a quick recovery time and good cuta-
2002 and 2003 by Bluggerman, Schavelzon, and neous retraction (Kim and Geronemus 2006).
Goldman, who introduced the concept of pulsed In this same year, the FDA approved the first
laser for laser lipolysis (Apfelberg et al. 1994). laser lipolysis equipment, an Nd: YAG laser of
In 2003, Badin founded these findings in one 6 W (produced by DEKA and distributed by
study titled “Laser Lipolysis: Flaccidity Under Cynosure, Westfort, Massachusetts). Soon after,
Control.” The author demonstrated the histologi- several equipments with different wavelengths
cal changes after the thermal laser injury. The entered the market (Table 1).
adipocytes’ membrane was torn, vessels were In 2007, Morton et al. detailed a mathematical
coagulated, and collagen was reorganized. These model that compared an equipment with a 980 nm
histological changes were correlated with the clin- laser diode to a 1064 nm Nd: YAG. This study
ical observation of reducing adiposity, ecchymo- suggested that regardless of the wavelength, what
sis, blood loss, and improvement of flaccidity. really drove the lipolysis and skin contraction was
Badin concluded that laser lipolysis was less trau- the heating. They have mentioned that the level of
matic because of the cannula’s smaller pitch and the internal temperature to achieve a contraction
that this type of laser, Nd: YAG, produced a tissue was from 48  C to 50  C (118–1222  F) (Morton
reaction leading to cutaneous retraction (Badin 2008).
et al. 2002). In 2008, McBean and Katz studied an equip-
In a subsequent study carried out by Goldman, ment which associated two wavelengths 1064 and
1734 patients were treated, including 313 men and 1320 nm, respectively, the SmartLipo ®. The
1421 women aged 15–78. In this group, less blood objectives of the study were to assess cutaneous
loss and ecchymosis, improvement of postopera- safety and effectiveness. The effect of cutaneous
tive comfort, and better effectiveness of fat reduc- retraction was documented by photographic doc-
tion in denser areas such as in gynecomastia, for umentation and measurement, as well as through
example, were also documented (Kim and histological studies and electron microscopy,
Geronemus 2006). which revealed study neocollagenesis. This was
Laser Lipolysis 247

the first study to demonstrate the clinical effects of in the tissue but low absorption by fat. However,
cutaneous retraction produced by laser lipolysis, its distribution of heating is superior with good
with objective measures proven by electron cutaneous retraction effect. Finally, the 1320
microscopy (Mcbean and Katz 2009). wavelength has demonstrated great absorption
In the same year, Palomar launched the by fat, but with low penetration in the tissue, so
Aspire™ platform (SlimLipo ®) in the market, a it is safe for treating more fragile skins, such as in
laser diode with two selective and safe wave- the neck and arm areas (Parlette and Kaminer
lengths, respectively, the 924 nm for fatty cells 2008).
and 975 nm, with greater selectivity for water in The different wavelengths have variable
the connective tissue, promoting cutaneous retrac- absorption coefficients for fat, water, and hemo-
tion (Mcbean and Katz 2009). globin. Fat contains approximately 14% of water,
Today, it became clear that laser lipolysis liq- and collagen contains 60–70%; therefore the
uefies fat and promotes remodeling of collagen appropriate selection of the laser allows a prefer-
fibers, improving flaccidity. Currently, new ential target of fat and/or water. When comparing
research aims to standardize the methods that light absorption by fat and by the dermis, we
will optimize results, safety, and efficacy. noticed that the highest selectivity to melt fat
Laser lipolysis is a new technique, a minimally happens when 924 nm laser diode is used. Due
invasive procedure for the treatment of localized to great absorption of light directly into fat, the
fat and laxity, improving facial and body contour. heating effect is limited to the fibrous septum of
It consists of the application of laser directly on fat and to the reticular dermis, preserving the
the adipose tissue, based on the principle of selec- underlying tissues, with less risks of thermal dam-
tive photothermolysis. This method has the age. Less trauma to the suction will be necessary
advantage to be less traumatic and to cause less due to great fat liquefaction (Parlette and Kaminer
bleeding, reducing the postoperative recovery 2008).
time when compared to conventional liposuction. There are multiple laser systems for lipolysis.
Since its approval by the FDA in October Current technologies use small optical fibers
2006, studies have corroborated for early clinic 1–2 mm thick to transmit the laser directly into
observation of the adipose tissue reduction, a the subcutaneous tissue; the 924 nm has the
rapid recovery, and flaccidity improvement. highest affinity for fat and less heating of the
Goldman has proposed that two properties must collagen. Therefore, it promotes larger liquefac-
be considered to determine the effectiveness of tion of fat and less tissue retraction (McBean and
laser lipolysis: wavelength and the energy Katz 2011).
employed. According to the theory of selective Rupture and liquefaction of the adipose tissue,
photothermolysis, these chromophores (fat, colla- coagulation of small blood and lymphatic vessels,
gen, and blood vessels) preferentially absorb the and collagenesis induction with tissue remodeling
laser energy based on the specific absorption coef- have been reported after laser lipolysis treatment.
ficient, according to the wavelength. Many wave- Other mechanisms of action such as photo-
lengths, including 924, 968, 980, 1064, 1319, 1320, acoustics and photomechanical effect have been
1344, and 1440 nm, have been evaluated by their purported (DiBernardo and Reyes 2009).
interaction with these chromophores. Many authors
suggest that certain wavelengths are more effective
for lipolysis (DiBernardo et al. 2009). Indications and Contraindications
Parlette and Kaminer have documented that the
924 nm wavelength has a higher selectivity to The primary indication of laser lipolysis is the
absorb fat, but it is not effective to induce cutane- treatment of localized fat through the liquefaction
ous retraction, improving laxity. They showed of the adipose tissue. Any location where there is
that 1064 nm wavelength has a good penetration localized fat and moderate flaccidity, including
248 P.A. Bellotti Schwartz de Azevedo et al.

Fig. 1 (a, b) Before and


after treatment with laser
lipolysis

the submental, arms, abdomen, flanks, the inner does not replace a healthy diet and physical exer-
surface of thighs, knees, and elbows, has an indi- cises (McBean and Katz 2011).
cation to this procedure because they simulta- There are no specific contraindications. Patients
neously promote cutaneous retraction through over 60 years old with cardiovascular disorders,
neocollagenesis. It is very well indicated for face hypertension, or diabetes should be carefully eval-
contour (Fig. 1a, b) (McBean and Katz 2011). uated. Additionally, patients with liver disease,
Patients with irregularities after liposuction and previous chemotherapy, and in use of antiretroviral
other surgeries are also excellent candidates. For medicine have risk of lidocaine toxicity (McBean
areas with more fibrous tissue such as male breast and Katz 2011).
(gynecomastia), flanks, and back, laser lipolysis
may be the only option. The small size of the
cannula facilitates the treatment in these fibrous Preoperative Considerations
areas without the additional trauma (McBean and
Katz 2011; Palm and Goldman 2009). During the consultation, complete anamneses
Recent articles described the use of laser lipol- should be performed, and the real objectives
ysis for the treatment of lipoma, considering that regarding the procedure must be identified
conventional surgeries for lesions bigger than (McBean and Katz 2011).
10 cm can result in disfiguring scars. Laser lipol- Drug allergies must be investigated. Patients
ysis alone or associated with aspiration by suction should be informed about drugs that should be
facilitates the removal of these tumors with a avoided before the procedure, such as warfarin,
better aesthetic result (Stebbins et al. 2011). clopidogrel bisulfate, aspirin, or other nonsteroi-
Other indications described are axillary hyper- dal anti-inflammatories, to avoid bleeding. Drugs
hidrosis and cellulite, still with questionable that inhibit the cytochrome P450 liver enzymes,
results. It can also be used in association with such as selective inhibitors of serotonin and anti-
other technologies, such as fractional CO2, in fungal azole agents, decrease the metabolism of
the submental to increase neocollagenesis and lidocaine and should also be avoided (McBean
cutaneous retraction internally and externally and Katz 2011).
(Parlette and Kaminer 2008). The laboratorial tests should be done to hold
Careful patient selection is crucial before the off some disorders in the liver, kidney, and blood.
procedure. The ideal candidate for laser lipolysis Some infections, such as HIV and hepatitis, and
is a healthy patient with little localized fat. It is pregnancy are also contraindication (McBean and
important to tell the patient that this procedure Katz 2011).
Laser Lipolysis 249

During the physical examination, the patient the basal body temperature. The procedure should
should be standing and without clothes. With the only be started after 20–30 min to allow a suitable
aim of obtaining better body contour, the patient fluid diffusion and adequate vasoconstriction.
may benefit from the treatment of adjacent areas, Besides promoting analgesia, the tumescent anes-
for example, to treat the abdomen and flanks, even thesia also increases the selectivity and effective-
when their initial complaint is limited to the abdo- ness of the laser (Klein 1993).
men (McBean and Katz 2011). The use of suitable goggles in the operating
To assess the tonus and the elasticity of the skin theater for everyone in the team, including the
on the area to be treated, the physician should patient, is a matter of safety (Palm and Goldman
perform the clamp test, in which the skin is gently 2009).
pulled between the forefinger and the thumb and The application of laser on the adipose tissue
subsequently released. If the skin instantly is performed through an 1.5 mm thick optical
returns, it indicates good elasticity. If the skin fiber directly on the tissue or inserted within a
returns slowly, it indicates poor elasticity. Patients cannula 2–3 mm thick. The optical fiber leads
with excess flaccidity are not good candidates not only the therapy light (924, 975, 1064,
(McBean and Katz 2011). 1320 nm) but also a guiding light of neon-
Previous photographic documentation is helium (634 nm), which allows the precise loca-
important and mandatory to identify all irregular- tion of the tip of the fiber, so the doctor is
ities, ripples, or previous scars and objectively constantly aware of the area of the laser opera-
evaluate the postoperative results (McBean and tion (Palm and Goldman 2009).
Katz 2011). The application technique happens through
A preinformed consent form with guidance quick, constant, and back and forth movements,
about the procedure and about postoperative as if moving a fan, to avoid overheating of the
cares should be signed by the patient before the treated area, preventing burns and consequently
procedure (Morton 2008). scars. The doctor will notice a decrease in tissue
resistance to the cannula movement, indicating
lipolysis. This parameter is used as a treatment
Technique endpoint. An infrared thermometer must be used
throughout the entire treatment to measure the
Laser lipolysis can be performed under local anes- external temperature, taking care not to exceed
thesia isolated or in association with intravenous 38–40 C (Palm and Goldman 2009).
sedation, epidural block, or general anesthesia. The resulting content of lipolysis is an oil
The type of anesthesia chosen depends on patient containing broken adipocytes and cellular debris,
health and preference and should be decided with mixed with the tumescent solution. Aspiration of
the doctor. The area to be treated must be marked this content is optional and is the doctor’s choice.
with the patient in the orthostatic position. Once The aspiration can be done through an external
marked, the patient is taken to the sterile surgical cannula 2–3 mm thick with negative pressure of
environment (Palm and Goldman 2009). 0.3–0.5 atm. Very small areas such as the sub-
Local anesthesia is performed through subcu- mental, with small volumes, recover well without
taneous infiltration of tumescent solution of aspiration (Morton 2008).
heated Klein or other similar solutions combining Regardless of aspiration, a manual drainage
lidocaine and epinephrine. The total volume of the must be performed while the patient is still in the
SC infiltration depends on the surgeon’s prefer- operating theater, and the cannula’s orifice must
ence and also on the size of the area to be treated. remain open to promote gradual output of the
The solution is heated to minimize any discomfort remaining content, which can occur up to 48 h
associated with the difference of temperature after procedure (Palm and Goldman 2009;
between tissue and fluid, in addition to maintain Stebbins et al. 2011).
250 P.A. Bellotti Schwartz de Azevedo et al.

Postoperative Care technique, pain, ecchymosis, and edema are


reduced, minimizing complications. In addition
It is recommended that patient uses compressive it promotes cutaneous retraction, avoiding laxity
meshes placed at the end of the procedure and after lipolysis, and has a short downtime.
maintained for a period of 2–4 weeks. The return
to routine activities occurs after the first 24 h, except
for intense physical activities, which can be taken Take Home Messages
up within 15 days. The manual lymphatic drainage
is initiated after 48 h, performed two to three times a • Laser lipolysis is a minimally invasive safe and
week for 15 days (Palm and Goldman 2009). effective procedure.
• Any location where there is localized fat and
moderate flaccidity, including the submental,
Results arms, abdomen, flanks, the inner surface of
thighs, knees, and elbows, has an indication
Although the initial clinical results can be similar to this.
to those obtained in a traditional liposuction, the • Induction of neocollagenesis and short down-
histological findings show some differences such time are the two major advantages.
as rapid recovery due to blood vessel coagulation • Complications are rare.
with peri- and post-procedure bleeding reduction.
In addition it promotes neocollagenesis and reor-
ganization of collagen in the reticular dermis, References
explaining the cutaneous retraction. This laser
Apfelberg DB, Rosenthal S, Hunstad JP, et al. Progress
capacity of producing retraction is very important
report on multicenter study of laser-assisted liposuc-
for the treatment of patients with some degree of tion. Aesthet Plast Surg. 1994;18(3):259–64.
flaccidity, who may not have indication of a tra- Badin AZ, Moraes LM, Gondek L, et al. Laser lipolysis:
ditional liposuction (DiBernardo and Reyes 2009; flaccidity under control. Aesthet Plast Surg. 2002;26
(5):335–9.
Palm and Goldman 2009; Morton et al. 2007;
DiBernardo BE, Reyes J. Evaluation of skin tightening
Goldman et al. 2011; Mann et al. 2008). after laser-assisted liposuction. Aesthet Surg
J. 2009;29(5):400–7.
Goldman A, Wollina U, Mundstock EC. Evaluation of
tissue tightening by the subdermal Nd:YAG laser-
Complications assisted liposuction versus liposuction alone. J Cutan
Aesthet Surg. 2011;4(2):122–8.
Katz BE, McBean JC. Laser-assisted lipolysis: the report
Complications are rare, and when they occur, they on complications. J Cosmet Laser Ther. 2008;10(4):
are not specific to the laser. Excessive energy or 231–3.
superficialization of the laser cannula can promote Kim KH, Geronemus RG. Lipolysis using a novel laser
burn with unaesthetic scar. Adverse effects such as 1064 nm Nd: YAG Laser. Dermatol Surg. 2006;32
(2):241–8.
ecchymosis, edema, asymmetries, and temporary Klein JA. Tumescent technique for local anesthesia
paresthesia are also reported and are similar to improves safety in large-volume liposuction. Plast
traditional liposuction (Katz and McBean 2008). Reconstr Surg. 1993;92(6):1085–98.
Mann MW, Palm MD, Sengelmann RD. New advances in
liposuction technology. Semin Cutan Med Surg.
2008;27:72–82.
Conclusion Mcbean JC, Katz B. The pilot study of the efficacy of a
1064nm and 1320 nm sequentially firing Nd: YAG
Laser lipolysis is a minimally invasive safe and laser device for lipolysis and skin tightening. Lasers
Surg Med. 2009;41(10):779–84.
effective procedure. It is a useful tool for body McBean JC, Katz BE. Laser lipolysis: an update. J Clin
and facial contouring treatment. Through this Aesthet Derm. 2011;4(7):25–34.
Laser Lipolysis 251

Morton MR. Mathematical modeling of laser lipolysis. Parlette EC, Kaminer ME. Laser-assisted liposuction:
Biomed Eng Online. 2008;7(1):10. here’s the skinny. Semin Cutan Med Surg. 2008;
Morton S, Eymard-Maurin AF, Wassmer B, et al. Histo- 27:259–63.
logic evaluation of lipolysis laser: pulsed Nd: YAG Stebbins WG, Hanke CW, Peterson J. Novel method of
laser 1064nm versus CW 980 nm diode laser. Aesthet minimally invasive removal of large lipoma after laser
Surg J. 2007;27(3):263–8. lipolysis with 980nm diode laser. Dermatol Ther.
Palm MD, Goldman MP. Laser lipolysis: current practices. 2011;24(1):125–30.
Semin Cutam Med Surg. 2009;28:212–9.

You might also like